Literature DB >> 2201703

Bacteroides gingivalis stimulates bone resorption via interleukin-1 production by mononuclear cells. The relative role for B. gingivalis endotoxin.

A A Bom-van Noorloos1, J W van der Meer, J S van de Gevel, E Schepens, T J van Steenbergen, E H Burger.   

Abstract

Supernatants of human peripheral blood mononuclear cells cultured in the presence of B. gingivalis, showed a strong osteoclast stimulating activity as measured by 45Ca release from fetal mouse long bones in vitro. These supernatants also contained a high concentration of bioactive and immunoreactive interleukin-1 (IL-1), but tumor necrosis factor (TNFa), another osteoclast-activating cytokine, was not detected. Osteoclast activation by the supernatants was inhibited by an antibody against IL-1, whereas ultrapure human IL-1 mimicked the effect of the supernatant. The ability of B. gingivalis to induce IL-1 and OAF production was heat sensitive, as 20 min heating of the bacteria at 120 degrees C caused a 50% loss of activity. In addition, purified B. gingivalis lipopolysaccharide (LPS) had little IL-1 inducing capacity, compared with LPS of Escherichia coli. These data suggest that human peripheral blood cells confronted with B. gingivalis produce large amounts of IL-1 which has strong osteoclast stimulating activity. However, in contrast with E. coli LPS, B. gingivalis LPS does not seem to be the major inducing agent. Thus other bacterial components must be responsible for the observed IL-1 and OAF induction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201703     DOI: 10.1111/j.1600-051x.1990.tb02338.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  9 in total

1.  CpG motifs in Porphyromonas gingivalis DNA stimulate interleukin-6 expression in human gingival fibroblasts.

Authors:  A Takeshita; K Imai; S Hanazawa
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts.

Authors:  A Watanabe; A Takeshita; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis.

Authors:  H Kadono; J Kido; M Kataoka; N Yamauchi; T Nagata
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics.

Authors:  Y Miyata; H Takeda; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide.

Authors:  C Y Chiang; G Kyritsis; D T Graves; S Amar
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype.

Authors:  Y Sakuma; K Tanaka; M Suda; Y Komatsu; A Yasoda; M Miura; A Ozasa; S Narumiya; Y Sugimoto; A Ichikawa; F Ushikubi; K Nakao
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

8.  Inflammatory cytokine gene expression in human periodontal ligament fibroblasts stimulated with bacterial lipopolysaccharides.

Authors:  Y Yamaji; T Kubota; K Sasaguri; S Sato; Y Suzuki; H Kumada; T Umemoto
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin.

Authors:  D M Dusek; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.